System
Archive
Molecular Neuroimaging Symposium 2010 Presentations
May 6-7, 2010
National Institutes of Health
Bethesda, Maryland
Click each session title to view the video presentation.
Note: Click the 
icon to view the PPT version or the 
icon to view the PDF version.
Due to their large size, some presentations may take a few minutes to download.
Program co-chairs: Michelle Bradbury, MD, PhD (Memorial Sloan Kettering Cancer Center) and Dima Hammoud, MD (Clinical Center, NIH)
Day 1
- Keynote Speech: Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan
horses
William Pardridge, MD (University of California, Los Angeles)
Session 1: Molecular Imaging Techniques: Intraoperative and preclinical imaging applications
- Optical molecularimaging technique
Hisataka Kobayashi, MD, PhD (National Cancer Institute/NIH) - Nuclear medicine techniques: SPECT/ micro-SPECT/CT
Benjamin Tsui, PhD (Johns Hopkins University) - Nuclear medicine techniques: simultaneous micro-PET/micro-MRI
Russell Jacobs, PhD (California Institute of Technology) - Intraoperative imaging for defining brain tumor margins
James P. Basilion, PhD (Case Western Reserve University)
Session 2: Nanotechnology for CNS diagnostics/therapeutics
- Nanotechnology based biosensors for imaging neural cells
Gabriel Silva, PhD (University of California, San Diego) - Nanoparticles cross the blood–brain barrier to enable 'brain tumor painting'
Miqin Zhang, PhD (University of Washington) - C dots: A novel silica nanoparticle platform for molecular imaging
Ulrich Wiesner, PhD (Cornell University, Ithaca) - Keynote speech: Imaging the Addicted Brain
Nora Volkow, MD (National Institute on Drug Abuse/NIH)
Session 3: Overcoming the blood–brain barrier: Imaging agent delivery to the CNS
- PET/SPECT imaging of multi-drug resistant P-glycoprotein: Transport activity monitoring associated with blood–brain barrier function
David Piwnica-Worms PhD, MD (Washington University in St. Louis) - PET agents for molecular imaging of tumor neovasculature
Xiaoyuan Chen, PhD (National Institute of Biomedical Imaging and Bioengineering/NIH) - Advances in the treatment of malignant glioma
Patrick Y. Wen, MD (Dana Farber/Brigham and Women's Cancer Center)
Session 4: Stem Cell Therapeutics and Adoptive Immunotherapies of Brain Tumors
- MR-based nanoprobes for mapping in vivo cell fate
Thomas J. Meade, PhD (Northwestern University) - Role of Therapeutic and diagnostic Stem Cells in Neuro-oncology
Khalid Shah, PhD (Massachusetts General Hospital, Harvard University) - Molecular imaging of therapeutic cells: Pre-clinical and clinical studies
Shahriar Yaghoubi, PhD (Stanford University) - Keynote Speech: Translating metabolic assays into molecular imaging diagnostics
Michael Phelps, PhD (University of California, Los Angeles)
Day 2
- Keynote Speech: Strategies to overcome the blood–brain barrier for treatment of brain tumors
Ed Neuwelt, MD (Oregon Health and Science University)
Session 5: Molecular Imaging Advances in the Evaluation of Primary Brain Tumors
- Imaging hypoxia and cell proliferation
Kenneth Krohn, PhD (University of Washington) - Metabolic brain tumor imaging using high-field MRI
Keith Thulborn MD, PhD (University of Illinois, Chicago) - Decoding gene expression in brain tumors using non-invasive imaging techniques
Michael Kuo, MD (University of California, Los Angeles)
Session 6: Imaging biomarkers for Detection and Monitoring Progression of Neurodegenerative Disorders/Dementia
- Human amyloid beta imaging in Alzheimer's disease: future tracer development
Chet Mathis, PhD (University of Pittsburgh) - Serial combined PIB-PET and MRI in Alzheimer's disease
Clifford Jack, MD (Mayo Clinic and Foundation) - Imaging and genetic biomarkers of Parkinson's disease risk, onset and progression
Kenneth Marek, MD (Institute for Neurodegenerative Disorders)
Session 7: Psychiatric/Neurobehavioral Research
- Neuroimaging abnormalities in early-onset mood disorders
Wayne Drevets, MD (Oklahoma University School of Medicine) - Molecular Imaging of the Depression-Dementia Continuum
Gwenn Smith, MD (Johns Hopkins University School of Medicine) - Imaging Genetic Influences in Schizophrenia
Karen Berman, MD (National Institute of Mental Health/NIH) - Keynote Speech: From Molecules to Networks to Behavior
Jeff Petrella, MD (Duke University Medical Center)